Akero Therapeutics, Inc. Current Ratio for the Trailing 12 Months (TTM) ending December 31, 2023: 24.77

Akero Therapeutics, Inc. Current Ratio is 24.77 for the Trailing 12 Months (TTM) ending December 31, 2023. Current ratio represents the short-term liquidity measurement, showing current assets' coverage of liabilities. Higher ratio implies better ability to meet short-term obligations.
  • Akero Therapeutics, Inc. Current Ratio for the Trailing 12 Months (TTM) ending December 31, 2021 was 12.06.
Key Data
Date Current Ratio Interest Coverage Ratio Return on Capital Employed (ROCE) Return on Equity (ROE)